Lab automation: choosing what to automate and in what order, what lab automation companies and robotic lab automation suppliers sell, and why automation lab projects overrun

Automation projects overrun for a consistent reason: the laboratory automates the step that looked most tedious rather than the step that constrains throughput, and the constraint moves somewhere else. The cheapest automation project is the one that starts by measuring where work actually queues. This page covers choosing what to automate, in what order, and what the vendors in this market are actually selling.

the FDA rule on electronic records and signatures a regulated lab's system must satisfy
Part 11
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the ISO/IEC standard testing and calibration labs are accredited against
17025

Figures in this panel are the rules a laboratory system of record is bought against, named from the regulations themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and says so rather than implying an index it does not hold.

Choosing what to automate

  1. Measure where work queues. Walk the process and find where samples wait, not where people complain. The constraint is frequently a manual data step, a plate sealing step or a review, rather than the pipetting everybody notices. Automating anything other than the constraint moves the queue rather than shortening it.
  2. Islands before integration. Individual automated stations with a person moving plates between them are cheaper, more robust and easier to reconfigure than an integrated workcell. Integrate only where the manual transfer is genuinely the constraint, because every integration multiplies the failure modes.
  3. Sample identity must survive the whole path. Barcodes, plate maps and their link to the system of record have to hold across every step. An automated process that cannot say which well came from which sample has automated the wrong thing, and this is the most common serious defect in these projects.
  4. Staff for it explicitly. Automation replaces manual work with configuration, maintenance and troubleshooting work, and that work needs somebody whose job it is. Laboratories that automate without assigning the role end up with expensive instruments used manually.
  5. Plan the failure modes. Decide what happens when a run fails halfway: whether samples are recoverable, whether the batch is lost, and how a partial run is recorded. Automation concentrates risk into fewer, larger events, and unplanned failure handling is where confidence is lost.

What lab automation companies actually sell

The market divides into instrument makers selling stations, integrators selling workcells assembled from several makers' instruments, and software vendors selling the scheduling layer. Understanding which of the three you are talking to explains most of what they recommend.

An integrator is the right partner for a genuine workcell and adds cost and a dependency. For islands, buying stations directly and keeping the integration human is usually better value.

The data side is half the project

Automation produces results faster than a manual process produces them, and if those results still reach the system of record by hand you have moved the bottleneck rather than removed it. Plan the data path with the physical one.

Where results support regulated work, the automated path and its records carry the same electronic records obligations as anything else, including what happens to a partial or failed run.

Common questions

What should a laboratory automate first?
The step where work actually queues, which is frequently a data or review step rather than the pipetting. Automating anything else moves the constraint rather than removing it.
Should I buy an integrated workcell?
Usually not first. Individual automated stations with a person moving plates are cheaper, more robust and easier to reconfigure. Integrate only where the manual transfer is genuinely the constraint.
Why do automation projects overrun?
Because the wrong step was automated, because sample identity was not designed to survive the whole path, or because nobody was assigned to configure and maintain the system. All three are decided before purchase.
Does automation reduce staffing?
It changes it. Manual work becomes configuration, maintenance and troubleshooting work, and that needs someone whose job it is. Laboratories that skip this end up running automated instruments by hand.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/lab-automation/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices